Laboratory evaluation of biotic and abiotic factors that may influence larvicidal activity of Bacillus thuringiensis serovar. israelensis against two Florida mosquito species. by American Mosquito Control Association
Joumal of the American Mosquito Control Association, l5(l):32-42, 1999
Copyright O 1999 by the American Mosquito Control Association, Inc.
LABORATORY EVALUATION OF BIOTIC AND ABIOTIC FACTORS
THAT MAY INFLUENCE LARVICIDAL ACTIVITY OF BACILLUS
THURINGIENSIS SEROVAR. /SRAELENS/S AGAINST TWO FLORIDA
MOSQUITO SPECIES
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ABSTRACT. A technical powder of Bacillus thuringiensis serovar. israelensis (B.r.i.) (VectoBaco TB 5,000
international toxic units [ITU]/mg), an aqueous suspension (VectoBac@ l2AS, 1,200 ITU/mg), and a granular
formulation (VectoBac@ CG, 200 ITU/mg) were tested in the laboratory under different biotic and abiotic
conditions for efficacy against larvae of saltwater (Aedes taeniorhynchus) and freshwater (Culex nigripalpus)
mosquitoes. Second-, 3rd-, and 4th-instar larvae of Cx. nigripalpus were 1.3-3-fold more susceptible to both
VectoBac TP and VectoBac l2AS than were the respective larval instars of Ae. taeniorhynchus.For each species,
2nd-instar larvae were several-fold more susceptible to these B.t i. preparations than were the 4th instars. In test
cups, Iarvae under lower densities exposed to B.t.i. concentrations sustained 5-9-fold higher mortalities than
larvae under high-density conditions. VectoBac TP and VectoBac 12AS stayed in suspension for up to 24 h
with similar larvicidal efficacy, which was greater at 32-35"C than at l5-20"C. At 60"C maintained for24h,
VectoBac l2AS was adversely affected 2-3-fold in terms of potency, but VectoBac TP was not affected. Sig-
nificant loss of potency of both VectoBac l2AS and VectoBac TP occurred when exposed to 35-37'C under
high light intensity (140,000-170,000 lux) for 6 h. Increasing salinity levels from 0 (fresh water) to 5OVo sea
water caused gradual efficacy declines of VectoBac l2AS and VectoBac TP against Ae. taeniorhynchus larvae.
VectoBac CG caused insignificant initial and residual (up to 8 days) larval mortalities ofboth mosquito species.
This formulation did not release the active ingredient of B.t.i. in any significant mosquito larvicidal concentration
in surface layers of wateq and the formulation was more effective in shallower water. Storage of all 3 formu-
lations under constant laboratory and variable field conditions for up to 8 months did not produce detectable
potency loss of these products.
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INTRODUCTION
In the state of Florida, 3 mosquito larval control
materials are presently approved by the state's De-
partment of Agriculture and Consumer Services.
These materials include Abate@ (temephos), Alto-
sid@ (s-methoprene), and Bacillus thuringiensis sei.'
ovar. israelensis (,B.r.i.). During 1994-95, nearly
459,000 acres of mosquito larval habitat in Florida
were treated with these 3 materials, approximately
half the acreage with Abate and a quarter each with
Altosid and B.t.i. (Florida Coordinating Council on
Mosquito Control 1998). Among the 3 materials,
B.t.i. is not a contact insecticide and has to be in-
gested by mosquito larvae to produce toxic effects.
It is considered to be the safest for the environment
because of its specificity for some Nematocera, par-
ticularly simuliid blackflies, mosquitoes, and, to
some degree, chironomid midges (Ali 1981, Merritt
et al. 1989, Becker et al. 1992). This biocide is also
compatible with integrated pest management (IPM)
designs, is frequently highly toxic to target pests,
and is readily available. Additionally, the develop-
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ment of resistance in mosquito larvae to B.t.i. is
relatively much less pronounced (Georgiou and
Wirth 1997). In spite of these attributes, the use of
B.t.i. for mosquito larviciding purposes has in-
creased at a rather low rate in recent years. The
probable reasons for this slow increase of B.t i, use
in mosquito control are its significantly higher cost
(Florida Coordinating Council on Mosquito Control
1998) and occasional control failures experienced
by some mosquito control programs employing
B.r.l. products for larval control in Florida fresh-
water and saltwater mosquito habitats (Van Handel
et al. 1995).
Laboratory and field mosquito larvicidal efflcacy
of B.t.i. depends upon a number of biotic and abi-
otic factors. Besides susceptibility differences of
various mosquito species, factors such as larval
stage, larval feeding behavior, water temperature,
water quality, light intensity, larval density, and
vegetative cover play an important role in the suc-
cess or failure of an application (Mulla et al. 1990,
Becker et al. 1992, Becker and Rettich 1994, Con-
soli et al. 1995). Nature of formulation, potency,
settling rate, shelf life, and method and timing of
application also can influence effectiveness of B.t.i.
(Becker and Rettich 1994, Consoli et al. 1995). The
primary aim of the present study was to elucidate
mosquito larvicidal efficacy of B.t.i. under different
biotic and abiotic conditions created in the labora-
tory. Specifically, the influence of larval age (in-
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star), larval feeding behavior, and efflcacy loss of
B.r.i. under different storage and environmental
conditions was studied. This research was deemed
necessary to improve understanding of B.t.i., lead-
ing to its proper and efficacious handling and use
in mosquito control programs. It should be pointed
out that some studies of the nature proposed here
were conducted more than 17 years ago (e.g., Van
Essen and Hembree 1980, Dame et al. 1981). How-
ever, since these studies, substantial improvements
in fermentation technology, toxicology, and quality
enhancements of B.r.i. products, as well as an in-
crease in commercial formulations (Wassmer
1995), have occurred, necessitating further efficacy
research.
MATERHLS AND METHODS
Mosquito species
For these studies, saltwater (Aedes taeniorhyn-
clras Wiedemann) and freshwater (Culex nigripal-
pas Theobald) mosquito species were used. For lab-
oratory bioassays, different larval instars from lab-
oratory-colonized Ae. taeniorhynchas at Florida
Medical Entomology Laboratory (FMEL), Vero
Beach, FL, and from wild-collected egg rafts of Cn.
nigripalpus from the Vero Beach area were reared
in artesian well water (pH 7.0) at 25 + l"C under
12 h lighVdark cycle.
Test formulations
One technical powder and 2 formulations of
B.r.i., VectoBac@ TP (technical powder, 5,000 in-
ternational toxic units [ITU]/mg, lor no. ll-134-
E5), VectoBac@ 12AS (aqueous suspension, 1,200
ITU/mg, lot no. 13-348-N9), and VectoBac@ CG
(corncob granules, 200 ITU/mg, lot no. 03-573-N8)
were tested. These materials were donated by Ab-
bott Laboratories, Chicago, IL.
Laboratory procedures
All laboratory bioassays conducted with
VectoBac l2AS and Vectobac TP followed the gen-
eral guidelines of the World Health Organization
(1981), with some modifications as described in Ali
et al. (1984). These formulations were mixed with
distilled water and suspended (magnetic stirrer) to
make LVo stock suspensions (voUvol or wt/vol). The
suspensions were maintained while making serial
dilutions as well as transfers for treatments. Six dif-
ferent concentrations of each formulation were used
for treatment purposes, The bioassays were done in
120-mt disposable plastic cups. Tlventy larvae of
the instar(s) and species to be tested were trans-
ferred to the cups, each containing 100 ml of well
water and 15 mg of larval food (liver powder and
brewer's yeast, 1:3 mixture). Each treatment was
replicated 3 times, and 3 untreated controls were
maintained in each test. Larval mortality readings
were noted at 24 h postffeatment. All bioassays,
unless otherwise stated, were conducted at 25 +
l"C maintained in controlled temperature rooms.
Each experiment was repeated at least twice on dif-
ferent days. Larval response to exposed dosages of
VectoBac TP and VectoBac 12AS was calculated
by a log/dose/probit regression analysis (United
States Environmental Protection Agency 1994).
Tests with VectoBac CG were conducted with
nalgene high-density polypropylene pans (each 54
x 43.5 cm surface and 13 cm deep) slightly tapered
from top to bottom (Fisher Scientific, Pittsburgh,
PA). The bioassay method in these pans was gen-
erally similar to that of Ali et al. (1994) with the
following modifications. A total of 100 3rd- and
4th-instar larvae of Ae. taeniorhynchus or Cx. ni-
gripalpus were released in 6 liters of well water
containing 100 mg of the mosquito larval food in
each pan. VectoBac CG granules needed for a treat-
ment rate of 2.5 kglha (typical field application
rates are 8-1 1 kg/ha) were randomly distributed on
the water surface in each pan at the beginning of
the experiment. The experiment was replicated 2
times, and 2 untreated pans were maintained as
controls. Larval mortality in the treated and control
pans was checked at 24 h posttreatment, and all
living and dead larvae from treated and control
pans were carefully removed with a droppe! count-
ed, and discarded. A new batch of lN Ae. tae-
niorhynchus or Cx. nigripalpus 3rd- and 4th-instar
live larvae and 50 mg of larval food were imme-
diately introduced into the treated and control pans.
This practice of daily larval introductions and 24-
h postintroduction mortality checks was continued
for 4 consecutive days (Monday-Thursday) for 2
wk; no larvae were introduced to the pans on Fri-
day, Saturday, and Sunday of each week. Larval
mortality data (corrected against controls) resulting
from these tests were analyzed by ANOVA to elu-
cidate residual activity of VectoBac CG utilized in
various experiments.
Laboratory experiments with VectoBac TP and
YectoBac 12AS
Susceptibility of various larval instars.' This ex-
periment utilized newly molted 2nd-,3rd-, and 4th-
instar larvae and older 4th-instar larvae (24 h and
48 h old) of Ae. taeniorhynchus and Cx. nigripalpus
to determine their susceptibility to different con-
centrations of VectoBac TP and VectoBac 12AS.
Effectiveness against various mosquito larval
densities: In this evaluation, newly molted 3rd- or
4th-instar larvae of Ae. taeniorhynchrrs and Cx, ni-
gripalpus were exposed to VectoBac TP and
VectoBac 12AS at densities of 20, 50, and lOO lar-
vae placed in 100 ml of well water in 120-ml dis-
posable bioassay cups to elucidate impact of larval
density on B.t.i. effectiveness.
Effect of water temperature.' This study utilized
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newly molted 3rd- and 4th-instar larvae of both
mosquito species. Larvae of each species and instar
were reured at 25"C and then separately acclima-
tized for 2 h at temperatures of 15, 25, and 35"C
prior to bioassay under these temperatures with
VectoBac TP and VectoBac 12AS to determine the
effectiveness of these materials under various tem-
peratures.
Effect of water salinity: Newly molted 3rd- and
4th-instar larvae of Ae. taeniorhynchus were uti-
lized. The larvae were reared in well water (0 sa-
linity). Sea salts (Sigma Chemical Co., St. Louis,
MO) were used to make 12.5, 25, and 507o sea-
water-salt concentrations in distilled water. Larvae
were acclimatized to these salinities for 2 h prior
to exposing them to VectoBac TP and VectoBac
l2AS prepared in different seawater concentrations
to determine salinity effects on B.t.i. activity.
Effect of settling in water: One percent stock so-
lutions of VectoBac TP and VectoBac 12AS were
made. These solutions were utilized to make 4-5
serial dilutions of each formulation in l-liter quan-
tities of well water. The dilutions were left undis-
turbed at 25'C. From these dilutions, appropriate
amounts of B.t.i.-treated water were carefully pi-
petted from the top 1 cm of each dilution at O,2,
6, and 24 h after preparation of the dilution. The
pipetted water was utilized to bioassay against new-
ly molted 3rd-instar larvae of Ae. taeniorhynchus
and Cr. nigripalpus and assess the activity profile
of B.t.i. toxin at or near the water surface, indicat-
ing its settling in time posttreatment.
Combined effect of sunlight and temperature:
Three separate sets of 5-6 dilutions of each
VectoBac 12AS and VectoBac TP in 100-ml clear
glass bottles were made from respective 17o stock
solutions. One set of serial dilutions of each mate-
rial was exposed to direct sunlight for 6 h, while
one similar set was kept in shade for 6 h, and an-
other kept under laboratory conditions for the same
time period. Light intensity and water temperature
were recorded hourly for 6 h at the location where
each set of bottles was placed; a light meter (Extech
Instruments, Model 4OlO25, Forestry Supplies,
Inc., Jackson, MS) was used to measure the light
intensity. After the exposures, the serial dilutions
were utilized to run standard bioassays in the lab-
oratory (25'C) against newly molted 3rd instar lar-
vae of Ae. taeniorhynchus.
Product storage effects at dffirent temperatures:
VectoBac TP and VectoBac l2AS were stored at 5,
25, 40, and 60"C for a 24-h period. These products
were previously stored at 5"C. Each formulation
was then bioassayed at 25 + loC against newly
molted 3rd- and 4th-instar larvae of Ae. taenior-
hynchus and Cx. nigripalpus. In another experi-
ment, VectoBac TP and VectoBac 12AS were
stored at 5 and 25'C for a 32-wk period. Samples
of each formulation were taken at 8-wk intervals
and tested in the laboratory against 3rd-instar Ae.
taeniorhynchas and Cx. nigripalpus.
Laboratory experiments with VectoBac CG
Effect of storage at dffirent temperatures.. This
experiment utilized 6 bags (each 20 kg) of
VectoBac CG purchased by Indian River Mosquito
Control District (IRMCD), Vero Beach, FL, from
Abbot Laboratories, North Chicago, IL. One of
these bags was opened and 2 samples (2.5 kg each)
were transferred into ziplock plastic bags and stored
at the FMEL at 5"C and at 25oC under 6OVo relative
humidity. The remaining granules were kept under
variable temperature (13-38"C) and humidity (40-
807o) conditions prevailing at the IRMCD's pesti-
cide storage facility. Samples of VectoBac CG
granules from each portion were taken at 0, 8, 16,
24, and 32 wk after storage and tested for efficacy
against 3rd-instar larvae of Ae. taeniorhynchas and
Cx. nigripalpus. The closed bags containing
VectoBac CG stored at the IRMCD's facility under
the variable temperature and humidity conditions
were opened 1 by 1 at 8-wk intervals, and a sample
of the granules taken from each bag was tested
against 3rd- and 4th-instar larvae of both mosquito
species at a rate of 2.5 kgha: the granules from
these bags were tested at 0, 8, L6, 24, and 32 wk
after storage.
Effect of water depth: VectoBac CG granules
were evaluated against 3rd-instar larvae of both
species at 2.5 kglha in 3 and 9 cm deep water in
Nalgene pans maintained at 25oC. One hundred lar-
vae of each species were introduced to the treated
pans for 4 days per week; dead and living larvae
were carefully removed from each pan after 24-h
exposure, and a new batch of 100 larvae was im-
mediately introduced. The experiment was repeated
twice to determine water depth effect on activity of
VectoBac CG.
Settling effect of granules: VectoBac CG gran-
ules were applied to 6 plastic pans at 2.5 kglha.
The pans contained 9-cm-deep water and were left
undisturbed at 25"C. After 30 min and l, 2, 4, 24,
and 48 h of application, 300 ml of water from the
surface (upper 10 mm) of each pan was carefully
removed with a 50-ml syringe and tested for tox-
icity to 3rd-instar larvae of Ae. taeniorhynchts and
Cx. nigripalpas in test cups to elucidate any B.t.i.
activity in top layers of water.
RESULTS
VectoBac TP and VectoBac 12AS
Susceptibility of vaious larval instars.' Compar-
ative susceptibility data of newly molted Znd-, 3id-,
and 4th (N)-instar larvae and older 4th-instar larvae
(24-h-old 4th [M] and 48-h-old 4th tl-l) of Cx. ni-
gripalpus and Ae. taeniorhynch&s to VectoBac TP
and VectoBac 12 AS are presented in Table 1. All
tested larval instars of Cx. nigipalpus were nearly
1.3-3-fold more susceptible to both B.r.i. materials
than were comparable larval instars of Ae. taenior-
hynchus. Among the 2 materials, the LCso and LCao
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Table l. Susceptibility of laboratory-reared Aedes taeniorhynchus and Culex nigripalpus (various larval instars) to
Bacillus thuringiensis serovar. israelensis formulations, VectoBac@ 12AS and VectoBac@ TP, in the laboratory.
24-h lethal concentration (LC) in ppm
35
Cx. nigripalpus Ae. taeniorhynchus
Larval instarl LCru LCno LCro LCnn
VectoBac-12AS (1,200 ITU/mg)
3rd
4th (N)
4th (M)
4th (L)
2nd
3rd
4th (N)
4th (M)
4th (L)
0.016
(0.010-0.023),
0.053
(0.038-0.066)
0.088
(0.081-0.098)
0 . 1 3 r
(0.1 l8-0.148)
0 .165
(0.145-O.186)
0.002
(0.001-0.002)
0.005
(0.00s-0.007)
0.009
(0.008-0.011)
0 .010
(0.008-{.01r)
0 .017
(0.015-0.019)
0.041
(0.028-{.079)
0 .102
(0.079-0.191)
0 .159
(0.137-0.200)
o.207
(o.r794.257)
o.272
(o.2374.329)
0.004
(0.003--0.006)
0 .016
(0.0r3-0.022)
0 .019
(0.016-0.024)
o.o25
(o.020-{.032)
0.037
(o.0244.O34)
o.o22
(0.012--0.036)
0.090
(0.080-0.103)
0.164(0.1 3s-0.20s)
0.208(0. r 84-0.240)
o.317(o.279-O.365)
0.005(0.0o4-o.006)
o.012
(0.009-0.016)
o.026(0.022-0.030)
0.036(0.013--0.061)
o.o32(o.oo74.o72)
0.055(0.034-{.167)
o.220(0.180-{.293)
0.328
(0.2524.sO3)
o.374
(0.310-{.503)
o.664(0.s64--0.884)
o.011(0.009-0.016)
0.040
(0.ot7-o.042)
0.068
(0.0s6-0.088)
0.060
(0.042-0.084)
o.067(0.040-o.080)
VectoBac TP (5,000 ITU/mg)
| 4th instar, newly molted (N), 24 h old (middle, M), and 48 h old (late, L).
'  95Vo fiducial limits in parentheses.
values of both mosquito species resulting from
VectoBac TP were 4-13 times lower than those
achieved by VectoBac l2AS. This result is to be
expected because VectoBac 12AS was 4.2-fold less
potent than VectoBac TP in terms of lTU/milli-
gram. The trend of declining susceptibility of each
species with increasing larval age (instar) is obvi-
ous from data in Table l. For example, newly molt-
ed 2nd-instar larvae of Cx. nigripalpus andAe. tae-
niorhynchus were 5.5- and 7.5-fold, respectively,
more susceptible to VectoBac 12AS than were their
respective newly molted 4th-instar counterparts, as
indicated by the LC.n values of these larval instars.
Also, within 4th-instar larvae, newly molted 4th in-
stars of both species were generally more suscep-
tible than late 4th instars with the exception of Ae.
taeniorhynchas exposed to VectoBac TP Specifi-
cally, the LC- values of newly molted and late 4th-
instar larvae of Cx. nigripalpus for VectoBac l2AS
were 0.159 and O.272 ppm, respecrively. Similarly,
for VectoBac TP, these values for Cx. nigripalpus
were 0.019 and 0.037 ppm; values (LCno) for Ae.
taeniorhynchus and VectoBac 12AS were 0.328
ppm (newly molted 4th instar) and O.664 ppm (late
4th instar).
Influence of larval densities: Efficacy of
VectoBac 12AS and VectoBac TP against Cx. ni-
gripalpus and Ae. taeniorhynchzs 3rd-instar larvae
declined with increased larval densities (Table 2).
For example, LCro values of 3rd-instar larvae of Cx.
nigripalpus against VectoBac 12AS were 0.053,
0.141, and O.423 ppm for the larval densities of 20,
50, and 100/cup, respectively, an 8-fold increase of
LC.o value between 20 larvae/cup and 10O larvael
cup. The trend of increase in LCrn values (VectoBac
12AS) of 4th-instar larvae of Cx. nigripalpr.r was
similar to that of the 3rd-instar larvae. with a 7-fold
increase of LCro value in 100 larvae/cup over 20
larvae/cup (data not included). Bioassays of 3rd-
instar larvae of Ae. taeniorhynchus with VectoBac
12AS followed a similar pattern of LCro value in-
creases with increased larval densities as observed
for Cx. nigripalpus. VectoBac TP essentially re-
vealed a similar pattern of dosage increase with in-
creased larval densities of 3rd instars of each spe-
cies. A nearly 9-fold increase of LCro values of 3rd-
instar larvae of Cx. nigripalpus occurred when per
cup density was increased from 20 to 10O; this in-
crease for Ae. taeniorhynchus amounted to nearly
5-fold. In general, the increases of LC.o values of
both mosquito species with increased larval densi-
ties were significantly correlated (r : 0.80, P <
O.05, n -- 24).
Effect of water temperature: Susceptibility of
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Table 2. Influence of various larval densities of Aedes taeniorhynchus and Culex nigripalpus 3rd-instar larvae on
effectiveness of Bacillus thuringiensis serovar. israelensis formulations, VectoBac@ 12AS and VectoBac@ TB
in the laboratory.
Species 20/cttp 50/cup 100/cup
vectoBac l2AS (1,200 ITU/mg)
Cx. nigripalpus
Ae. taeniorhynchus
vectoBac TP (5,000 ITU/mg)
Cx. nigripalpus
Ae. taeniorhynchus
0.053(0.038--0.066),
0.090(0.080-0.103)
0.005(0.00s-0.0o7)
o.ot2(0.001-0.069)
0 . 1 4 1(0.0es-0.2se)
0.32r(o.257-O.416)
0.o16(o.010--0.0r9)
0.036(0.02s--0.045)
o.423(o.4014.444)
0.499(0.475-O.524)
0.o47(0.060-o.260)
0.055(0.04ffi.06s)
' 100 ml water in each cup.
2 95Vo fidtcial limits in parentheses.
3rd-instar Cx. nigripalpzs and Ae. taeniorhynchus
to both VectoBac 12AS and VectoBac TP generally
increased with increased temperature in the labo-
ratory. Third-instar larvae of both species were
1.4-3.0-fold more susceptible to both B.r.l. mate-
rials at 35oC than at 15'C (Table 3). In contrast, the
increase in susceptibility of 4th-instar larvae of
both mosquito species with temperature increase
was inconsistent and showed maximum suscepti-
bility of 4th-instar larvae of both species at 25oC to
VectoBac l2AS as well as to VectoBac TP
Effect of water salinity.' Susceptibility of 3rd-
and 4th-instar larvae of Ae. taeniorhynchus to
VectoBac 12AS as well as to VectoBac TP gradu-
ally decreased with increased salinity (Table 4). The
LCro values (VectoBac 12AS) in well water to 5OVo
Thble 3. Susceptibility of Aedes taeniorhynchus and, Culex nigripalpus 3rd- and 4th-instar larvae exposed to
Bacillus thuringiensis serovar. israelensis formulations, VectoBac@ 12AS and VectoBac@ TB and maintained under
different temperatures during bioassays in the laboratory.
24-h LCso (ppm) values at various temperaturesSpecies and
larval instar l5"c 25"C 35'C
VectoBac 12AS (1,200 ITU/mg)
Cx. nigripalpus
3rd
4th
Ae. taeniorhynchus
3rd
4th
VectoBac TP (5,000 ITU/mg)
Cx. nigripalpus
3rd
4th
Ae. taeniorhynchus
3rd
4th
0.094
(0.087-0.101)'
o.r52(0.123-0. r68)
o.o72(0.064-{.080)
o.292(0.268--0.330)
0.018(0.016-0.020)
0.017(0.016--0.019)
0-009(o.o08-o.o10)
0.049(o.02o-{.067)
o.o'74
(0.069-o.080)
0 .139
(0.091--0.r57)
0.056
(0.049-0.063)
o.202
(o.18i l .221)
0 .011
(0.010-0.013)
0 .013
(0.010-o.016)
0 .010
(o.0o7--o.o1r)
0.028
(0.025--0.030)
0.066(0.0s7--0.077)
0.140(0.127-O.ls9)
0.o52(0.04s-0.0s9)
o.224(o.2o3-o.247)
0.006(0.002-0.012)
0.016(0.0r4-o.ol7)
0.005(0.ool-{.160)
0.036(0.033--0.o39)
' 95Vo fiducial limits in parentheses
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Table 4. Susceptibility of Aedes taeniorhynchus 3rd- and 4th-instar larvae exposed for 24 h to Bacillus
thuringiensis serovar. israelensis formulations, VectoBac@ 12AS and VectoBac@ TP, in different water salinities in
the laboratory.
24-h LC5o (ppm) values in well water and seawater
SeawaterLarval
instar Well water 12.5Vo 25Vo 50Vo
3rd
4th
3rd
4th
VectoBac l2AS (1,200 ITU/mg)
0.107
(0.098-{.1l7)r
o.219
(o.2oo4.224)
VectoBac TP (5,000 ITU/mg)
o.026(0.015-0.037)
0.031(0.028-{.034)
0.1 53(0.139-0.170)
o.312(0.2644.35s)
0.035(0.029-0.040)
0.045(0.04r--0.049)
o.t94(0.136-0.261)
o.334(0.30r-0.368)
0.040(0.031-o.044)
0.061(0.047-{.083)
o.226(0.1964.2s9)
o.444(0.390-0.493)
o.o42(0.036-0.047)
0.107(0.096-0.1 29)
I 95Vo fidrcial limits in prentheses.
sea water showed a nearly 2-fold increase for both
larval instars (0.107 to 0.226 ppm [3rd instar] and
0.219 to 0.444 ppm [4th instar]); the increase was
more pronounced (3.5-fold) in 4th-instar larvae ex-
posed to VectoBac TP, where LCro values of 0.031
ppm in well water and 0.107 ppm in 5OVo seawater
were observed.
Effect of settling in water: The LCro data of both
mosquito species (Table 5) indicate the settling
property difference of VectoBac 12AS and
VectoBac TP in water. The nearly 2-fold increase
of LC50 values of 3rd-instar Ae. taeniorhynchus(LC,o: 0.111 to 0.216 ppm) and Cx. nigripalpus(LC.o: 0.045 to 0.103 ppm) at O to 24 h is indicative
of diminishing B.t.i. active ingredient in VectoBac
12AS from surface water. VectoBac TP was rela-
tively slower in settling, as shown by Ae. taenior-
hynchus LCro values of 0.019 ppm at 0 h and 0.028
ppm at 24 h; Cx. nigripalpus, however, showed no
change of LCro values between 0 and 24 h with
VectoBac TP
Combined effect of sunlight and temperature:
The LCro values of 3rd-instar Ae. taeniorhynchus
with VectoBac 12AS and VectoBac TP kept under
shade (24-28'C, 800-1700 lux) and in the labora-
tory (25"C, 80O lux) were similar. For example,
VectoBac l2AS LCso values were 0.062 ppm
(shade) and 0.061 ppm (laboratory), and VectoBac
TP LC50 values were 0.023 ppm (shade and labo-
ratory) (Table 6). However, the activity loss of both
B.t.i. mateials exposed to sunlight (25-37"C,
110,500-164,500 lux) is evident from the nearly
12- and 3-fold increases of LCro values with
VectoBac l2AS and VectoBac TP, respectively.
Effect of product storage at dffirent tempera-
tures.' No susceptibility difference between 3rd- as
well as 4th-instar larvae of Ae. taeniorhynchrs and
Cx. nigripalprs was noted with VectoBac 12AS and
VectoBac TP stored at 5 and 25"C;the LCro values
of each instar and each species against each of
these products for the 2 storage temperatures were
the same or very similar (Thble 7). At 40 and 6O"C
Table 5. Effect of Bacillas thuringiensis serovar. israelensis formulations, VectoBac@ l2AS and VectoBac@ Tp
settling in water allowed for various time durations on its larvicidal activity against 3rd-instar larvae of Aedes
taeniorhynchus and Culex nigripalpus in the laboratory.
24-h LC5o (ppm) values for various settling time durations
Species 6 h  2 4 h2 h0 h
VectoBac 12AS (1,200 ITU/mg)
Ae. taeniorhynchus 0.lll
(0.099{) .123) l
Cx. nigripalpus 0.045
(0.041-{.049)
VectoBac TP (5,000 ITU/rng)
Ae. taeniorhynchus 0.019
(0.0r3-{.025)
Cx. nigripalpus 0.008(0.005-0.0r 1)
0.089(0.059-{.136)
0.063(0.0s 1-o.072)
o.o2l(o.or44.027)
0.008(0.006-0.010)
0.157(0.1424.r73)
o.o79(0.05s-o.125)
o.026(o.0234.O29)
0.007(0.006-0.008)
o.216(o.r974.297)
0.103(o.090-{.1l6)
0.028(0.017-0.035)
0.008(0.002-0.01s)
' 95Vo fiducial limits in prentheses
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Table 6. Laboratory susceptibility of 3rd-instar Aedes taeniorhynchus larvae to Bacillus thuringiensis serovar,
israelensis (B.l.l.) formulations, VectoBac@ 12AS and VectoBac@ TP, exposed to various light and temperature
conditions prior to bioassays.
24-hLCst (ppm) values with B.l.i. formulations exposed to
various light and temperature conditions
Formulation Sunlight' Shade'  Laboratory3
VectoBac l2AS
VectoBac TP
0.742
(o.6694.822)4
0.067
(o.062-0.073)
o.062(0.0s8-0.067)
o.o23(0.0r7-0.034)
0.061
(0.057-0.064)
o.o23
(0.01H.032)
| 25-37"C, I 10,500-164,500 lux.
'  24-28"C. 80O-1.700 lux.
3 25'C, 80O lux.
a 95Vo fiducial limits in parentheses.
storage temperatures, susceptibility of 3rd- and 4th-
instar larvae of Ae. taeniorhynchus to VectoBac
12AS and VectoBac TP decreased 1.6-3.7- and
1.2-2.t-fold, respectively, as compared with the
susceptibility levels at 5 or 25'C. Susceptibility de-
clines of Cx. nigripalpus larvae ranged from 1.1-
to 5.7-fold (VectoBac 12AS) and 1.6- to 2.7-fold
(VectoBac TP) at storage temperatures of 40 and
6O'C as compared with 5 and 25'C.
Storage of VectoBac 12AS and VectoBac TP at
5 and 25'C for O-32 wk produced no susceptibility
declines of 3rd-instar Cx. nigripalpzs larvae with
either formulation stored at 5'C for 32 wk (Table
8). However, at 25"C, susceptibility of Cx. nigri-
palpus declined 1.3- and 4.2-fold against VectoBac
12AS and VectoBac TP, respectively, at 32 wk of
storage. Susceptibility changes of 3rd-instar Ae.
taeniorhynchzs larvae at the 8-wk evaluations also
revealed some decline in effectiveness of both B.r.i.
formulations at 5oC as well as 25oC due to storase
(Table 8).
VectoBac CG
Effect of storage at dffirent temperatures.' Table
9 presents data on larval mortality of Ae. taenior-
hynchus exposed to VectoBac CG stored for vari-
ous lengths of time at 5"C, 25'C, and variable tem-
perature and humidity conditions. Under different
storage conditions, larval mortalities of Ae. tae-
niorhynchus during the 32-wk storage period
ranged between 94 and IOOVo at I day posttreat-
ment, with significant (P < 0.05) differences break-
ing out after 8 days posttreatment. At 10 days post-
treatment, larval mortality with granules stored
under all 4 conditions dropped significantly (P <
0.001), with a range from 45 to 85Vo for the 32-wk
storage period. Larvae of Cx. nigripalpus revealed
relatively less residual mortality effects of
VectoBac CG under different storage conditions
studied in this experiment (data not included).
However, VectoBac CG stored at 5'C and 25"C pro-
duced overall higher larval mortalities in Cx. ni-
gripalpus than did the granules exposed to variable
temperature and humidity conditions.
Effect of water depth: Larval mortality of Ae.
taeniorhynchlls ranged from 95 to IOOVo at 1 day
posttreatment in both 3-cm and 9-cm water depths
treated with VectoBac CG at2.5 kg/ha. Larval mor-
tality showed a significant decrease (95Eo to TOEI)
during subsequent 3 days in pans containing 9 cm
of water, whereas no such larval mortality declines
in pans containing 3 cm deep water were noted
(data not included). Larval mortality of Cx. nigri-
palpus ranged from 93 to IOOVo at 1 day posttreat-
ment in both 3-cm and 9-cm depths. In subsequent
days, a significant decline of larval mortality in
both water depths was noted (data not included).
Settling effect of granules: Tlte bioassay results
showed no larval mortality of either species (data
not presented). These results suggested that when
VectoBac CG was applied to the water surface and
the water remained undisturbed. the VectoBac CG
settled to the bottom of the pans; the active ingre-
dient did not go into suspension at the surface and,
thus, did not become available in any significant
mosquito larvicidal concentrations at or near sur-
face of the treated water.
DISCUSSION
Growth and development of mosquito larvae in-
cluding Cx. nigripalpus andAe. taeniorhynchus are
affected by both biotic and abiotic factors, such as
nutrition, population density, salinity of the rearing
medium, light-dark regimes, and temperature
(Nayar 1967, 1968; Clements 1992). It is therefore
logical that larval susceptibility of these species to
a control agent would also be affected by these fac-
tors. Howevet in the case of B.t.i., efficacy of a
formulation may also be affected by other abiotic
factors, such as physical nature and release mech-
anism of active ingredient, potency, settling rate,
and shelflife. The effects ofthese biotic and abiotic
factors on the mosquito larvicidal efficacy of tested
B.r.i. formulations is discussed.
Mosquito larvae feed constantly and grow con-
tinuously throughout each instar except for very
brief periods just before and after each molt (Cle-
ments 1992). Because 2nd-instar Ae. taeniorhyn-
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Table 7. Laboratory susceptibility of Aedes taeniorhynchus and Culex nigripctlpus 3rd. and 4th-instar larvae to
Bacillus thuringiensis serovar. israelensis formulations, VectoBac@ l2AS and VectoBac@ TP stored at different
temperatures immediately prior to the bioassays.
24-h LC5o (ppm) values for various temperatures
39
Species and
larval instar 5'C 25"C 60'c40'c
VectoBac 12AS (1,200 ITU/mg)
Cx. nigripalpus
3rd
4rh
Ae. taeniorhynchus
3rd
4th
VectoBac TP (5,000 ITU/mg)
Cx. nigripalpus
3rd
4th
Ae. taeniorhynchus
3rd
4rh
0.053(0.038-0.066)r
0.088(0.081-0.098)
0.090(0.080-{.103)
o.164(0.135-0.148)
0.005(0.004-{.007)
0.009
(0.008-0.01l)
0.012(0.009-{.016)
o.026(0.022-o.030)
0.048(0.038-{.058)
0.088(0.081-{.098)
0.090(0.080-0.103)
0.164(0. 135--0.205)
0.005(0.0(X-{.007)
0.009(0.008-{.011)
0.012(0.001-{.069)
o.026(o.022-0.03o)
0.058(0.052-o.069)
o.126(0. 106--0.146)
0.140(0.130-0.15r)
0.288(o.22s-o.322)
0.008(0.00s-0.010)
0.019(0.008-0.02s)
o.o23(0.016-0.030)
o.032(0.026-{.037)
o.124(0.113-0.139)
0.500
(0.461-0.541)
o.334(o.2214.646)
0.569(0.35s--0.715)
0.010(0.009-{.011)
o.o24
(o.0224.o27)
o.o25(0.019{.033)
0.038(0.034{.o43)
I 95Vo fiducial limits in puentheses.
chus and Cx. nigripalpls larvae are much smaller
than 4th-instar larvae and differ in their feeding be-
havior and mechanics of filtration, they were 6-8-
fold more susceptible to VectoBac 12AS and
VectoBac TP than were their respective 4th-instar
larvae. Their 3rd-instar larvae were 2-6-fold more
susceptible to these B.r.i. formulations than were
the 4th-instar larvae. Similar patterns of larval sus-
ceptibility were observed in other mosquito species
with different B.r.i. formulations (Van Essen and
Hembree 1980, Lacey and Oldacre 1983, Becker
and Rettich 1994). Therefore, it is advisable to
make field applications with the aqueous suspen-
sion and the technical powder formulations of B.t.i.
to 2nd- and/or 3rd-instar larvae rather than 4th-in-
star larvae. Regarding the susceptibility difference
between Ae. taeniorhynchus and Cx. nigripalpus to
a B.t.i. formulation, the results are in agreement
with previous observations of Ali et al. (1984),
where C-r. nigripalpus larvae were found to be
nearly 2-fold more susceptible than Ae. taeniorhyn-
chus larvae of the same instar to a VectoBac wet-
table powder tested in freshwater. Similar results
were reported by Becker and Rettich (1994) when
they tested Aedes cantans (Meigen), Aedes vexans
(Meigen), and, Culex pipiens L. larvae, with Cx.
pipiens being more susceptible than the Aedes lar-
vae,
High larval density of mosquitoes per unit area
(volume) results in longer development time, re-
duced pupal success, and reduced pupal weight
(Clements 1992). Hence, density of larvae in a hab-
itat can affect susceptibility of larvae to the B.t i.
Especially in the case of B.t.i., under high larval
density conditions, competition for ingestion of
B.t.i. active ingredient (6-endotoxin) will be greater.
Our observations of lower larval densities of both
species requiring 2-6-fold less .B.r.i. than the higher
densities agree with similar reports on other species
of mosquitoes (Mulla et al. 1990, Becker et al.
1992). Therefore, it is necessary in the field to
make subjective adjustments of rates of B.t.i. ap-
plications depending upon prevailing larval densi-
ties.
Growth and development of mosquito larvae oc-
cur only within a temperature range that is deflned
by lower development threshold and upper lethal
limit, and with this temperature range, the rates of
growth and development are positively correlated
with temperature (Clements t992). This tempera-
ture range is species specific. In both Cx. nigripal-
pus and Ae, taeniorhynchus, the lower develop-
mental threshold and lethal limits are 15 and 35'C.
respectively (Nayar 1967, 1968). Lower tempera-
ture (15"C) of water slows the development of lar-
vae, with the result that larvae consume fewer nu-
trients (and also less 6-endotoxin) and apparently
become less susceptible. Higher temperatures
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Table 8. Laboratory susceptibility of Aedes taeniorhynchus and Culex nigripalpus 3rd-instar larvae to Bacillus
thuringiensis serovar. israelensis formulations, VectoBac@ l2AS and VectoBac@ TP, stored at 5 and 25'C for various
time periods prior to the bioassays.
24-h LC5o (ppm) values for various storage periodsSpecies and
storage temp 8 w k 16 wk 24 wk 32 wk
Cx. nigripalpus
5'C
25"C
vectoBac 12AS (1,200 ITU/mg)
0.053
(0.038-0.066)'
0.048(0.038-0.058)
Ae. taeniorhynchus
5'C 0.090
(0.080-o.103)
2s"c 0.090
(0.080-0.103)
VectoBac TP (5,000 ITU/mg)
Cx. nigripalpus
5'C
25"C
Ae. taeniorhynchus
5'C
25"C
l3-38"C/4O-8OVo
test granules
obtained from
a new bag opened
at 8-wk intervals)
0.058
(0.051-0.064)
o.o44(0.003-0.089)
0.1 55(0.103--0.130)
o.154
(0.128-{.r96)
0.007(0.006-0.008)
0.007(0.0o5-o.0o8)
0.014
(0.021-o.016)
0.039(0.030-o.M7)
0.056
(0.048--0.066)
0.048(0.040-{.058)
o. t t2(0.090-0.1 20)
o.152
(0.152-O.1s9)
0.007(0.002-{.014)
0.ol I(0.o04-o.021)
o.o24(0.021-o.031)
0.038(0.029-{.048)
0.049
(0.044-{.053)
0.058(0.051-0.065)
0 . 1 1 6(0. 108--0.122)
0.159(0. 142--0. l6s)
o.007(0.004-0.012)
0.010(0.004-o.021)
o.026(0.021-o.028)
0.033(0.028-0.041)
0.053(0.048-0.0s8)
0.065(o.06r-0.069)
0 .110(0.088-o. r42)
o.t4'7
(o.1344.162)
0.007(o.0o3-{.012)
o.o2l(o.019-{.022)
o.026(0.Oos-0.037)
0.025
r9-o.032)
0.005(0.00s-{.007)
o.00s(0.005-0.007)
0.012(0.0o9-0.016)
0.012(0.001-0.069)
\ 959o fidtcial limits in parentheses.
Table 9. Efficacy of Bacillus thuringiensis serovar. israelensis formulation VectoBac@ CG (200 ) stored for
various lengths of time (weeks) under 5'C, 25"C, and variable temperature (13-38"C) and (4O-8OVo)
conditions and evaluated at 2.5 kglha against 3rd- and 4th-instar larvae of Aedes taeniorhynchus in maintained
at 25"C in the laboratory.
Storage
temp/RH
Mean Vo larval mortality posttreatment
Weeks  l day  2days  3days 4 days 8 days 9 lO days
5"Cl6OVo
25"Cl6OVo
I3-38"C/4O-8OVo
75
60
62
72
I J
76
5 8
6 l
47
0 100 100 96 95 94
8 100 100 97 86 84
16 100 100 99 98 96
24 100 97 86 86 85
32 98 96 88 86 85
0 100 100 96 95 94
8 9 9 9 8 9 5 9 4 9 0
16 98 97 93 78 76
24 100 100 91 90 88
32 97 96 94 87 86
0 100 100 96 95 94
8 100 99 97 73 73
16 100 100 98 85 85
24 99 98 96 86 83
32 94 92 83 80 80
0 100 100 96 95 94
8 100 100 93 84 77
16 100 99 98 95 93
24 98 98 98 90 85
32 99 97 97 66 65
75
5 l
75
48
45
I J
45
85
'76
50
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(35"C) accelerate development of larvae, with the
result that the larvae consume more nutrients and
become more susceptible. This is why the efficacy
of VectoBac 12AS and VectoBac TP was higher at
higher temperatures (32-35"C) than at lower tem-
peratures (15-20'C). Similar observations were re-
ported on other mosquitoes species by Mulla et al.
(1990) and Becker et al. (1992). Thus, higher field
application rates of B.t.i. may be necessary during
fall and spring months than during summer months
to achieve the same level of control.
Aedes taeniorhynchus larvae breed in waters
ranging in salinity from slightly brackish to nearly
50Eo seawater (Nayar 1967). These larvae can
adapt to the prevailing salinity concentration and
can either retard their development in high salinity
or accelerate development in low salinity condi-
tions. Thus, when the salinity of water in Ae. tae-
niorhynchus habitats increases because of high tem-
perature and evaporation of water, the larvae be-
come less susceptible to B.t.i. formulations than
when it rains and salinity levels are diluted. There-
fore, higher treatment rates of B.r.l. formulations
may be required during summer months, when
there is little rain and the water levels in the mos-
quito habitats are relatively low or when high sa-
linity tides stimulate egg hatch.
Increased sunlight has been shown to lower the
efficacy of B.t.i. (Morris 1983, Becker et al. L992).
However, in the tropics and subtropics, where the
intensity of sunlight as well as the water tempera-
ture are high, especially during the summer months,
the combined effect of higher intensity of sunlight
and high temperature can reduce the potency of
B.r.i. formulations substantially even when aqueous
suspension and technical powder formulations of
B.t.i. are exposed only for 6 h of a day. This sug-
gests that, ideally, field applications of B.r.i. should
be made during the later part of the day (after 4:00
p.m.) rather than in the morning hours, particularly
during the summer months.
Our laboratory results showed that both
VectoBac 12AS and VectoBac TP remained sus-
pended in solution for up to 24 h. VectoBac 12AS
showed a2-fold decrease in activity from 0 hto24
h, whereas VectoBac TP showed no difference in
activity. Therefore, these formulations were avail-
able to larvae for ingestion and caused significant
larval mortalities. However, when Becker and Ret-
tich (1994) tested Teknar@ TC powder (I3,5OO Ae-
des aegypti units [AAU]/mg), less than 507o of the
b-endotoxin remained in the top I cm of the water
atter 25 min, less than2OVo remained after 2h, and
less than 2Vo was available after 24 h. On the other
hand, when Teknar@ HP-D FC (flowable concen-
trate) (3,0OO AAU/mg) was tested (Becker and Ret-
tich 1994), more than SOVo of the toxin remained
available in the upper 1 cm layer of water after 25
min, more than 6OVo after 2 h, and less tlaar' lOVo
after 24 h. In our bioassay study with VectoBac
CG-treated wate! the granules settled rather rapidly
after application in test pans and did not release the
active ingredient at or near the surface of the 9-cm-
deep water to produce any larval mortalities. How-
eve! releasing Ae. taeniorhynchus larvae directly
into VectoBac CG-treated tubs containing 15-cm-
deep water resulted in excellent short-term as well
as sustained control for 7-10 days (Ali et al. 1994).
Our results with VectoBac CG in the pans were
compatible with the observations of Ali et al.(ree4).
Our results also showed that storage of all 3 for-
mulations of B.t.i. under normal environmental
conditions (temperature : 20-35'C and RH 60-
80Vo\ for up to 8 months did not significantly de-
crease their potency. However, storage of these
products at temperatures )40"C and high humidity
conditions (8O-9OVo) for any long period should be
avoided. Consideration of the above discussed bi-
otic and abiotic factors should maximize larval con-
trol of mosquitoes in the field through efficient use
of tlre B.t.i. products.
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